| Without diabetes (n = 1337) | Diabetes on OAD (n = 387) | Diabetes on insulin (n = 276) | p-value | HR (95% CI)* | p-value* |
---|---|---|---|---|---|---|
Total mortality | 68 (5.1) | 17 (4.4) | 21 (7.6) | 0.255 | 1.05 (0.69–1.60) | 0.814 |
 Cardiovascular death | 45 (3.4) | 15 (3.9) | 15 (5.4) | 0.212 | 0.91 (0.56–1.48) | 0.711 |
 Noncardiovascular death | 23 (1.7) | 2 (0.5) | 6 (2.2) | 0.160 | 1.46 (0.64–3.36) | 0.369 |
Myocardial infarction | 14 (1.0) | 7 (1.8) | 4 (1.4) | 0.379 | 0.58 (0.26–1.33) | 0.201 |
Stroke | 78 (5.8) | 14 (3.6) | 13 (4.7) | 0.110 | 1.49 (0.94–2.35) | 0.088 |
 Major/disabling stroke | 29 (2.2) | 8 (2.1) | 8 (2.9) | 0.731 | 0.94 (0.50–1.76) | 0.854 |
 Minor stroke | 49 (3.7) | 6 (1.6) | 5 (1.8) | 0.046 | 2.19 (1.11–4.3) | 0.023 |
Bleeding | 254 (19.0) | 71 (18.3) | 58 (21.0) | 0.809 | 0.96 (0.75–1.22) | 0.735 |
 Life-threatening or major | 127 (9.5) | 33 (8.5) | 31 (11.2) | 0.936 | 1.02 (0.73–1.46) | 0.927 |
 Minor | 127 (9.5) | 38 (9.8) | 27 (9.8) | 0.872 | 0.91 (0.66–1.26) | 0.584 |
Renal complications | 302 (22.6) | 115 (29.7) | 101 (36.6) | < 0.001 | 1.46 (1.18–1.81) | < 0.001 |
 Stage 2/3 | 36 (2.7) | 13 (3.4) | 13 (4.7) | 0.170 | 0.73 (0.43–1.24) | 0.248 |
Vascular complications | 123 (9.2) | 39 (10.1) | 22 (8.0) | 0.652 | 0.94 (0.67–1.31) | 0.713 |
 Major | 39 (2.9) | 14 (3.6) | 12 (4.3) | 0.428 | 0.74 (0.44–1.24) | 0.255 |
 Minor | 84 (6.3) | 25 (6.5) | 10 (3.6) | 0.211 | 1.09 (0.72–1.66) | 0.676 |
New PPM implantation | 175/1167 (15.0) | 45/340 (13.2) | 43/228 (18.9) | 0.180 | 0.96 (0.72–1.27) | 0.753 |